About Us

Healios Oncology Nutrition, LLC, is a Houston, Texas-based company that manufactures proprietary dietary supplements as an adjunctive nutritional support for cancer patients, dental patients, and others who are experiencing mucosal stress.

The company’s flagship product is Healios™ Glutamine Complex, a product designed to promote healthy mucosal tissues in patients receiving multiple therapies, including biological (for example which target the mTOR pathway), chemotherapy (for example doxorubicin and other agents known to cause mouth, throat or esophageal soreness), and radiation treatment (especially involving mouth, head, neck, and esophagus).

The benefits of supplementing one’s diet with the nutrients found in Healios™ has been clinically demonstrated in published scientific studies and the nutritional benefits of Healios™ are now being further studied at a world-class cancer hospital.

You can learn more about Healios as it relates to your requrements by by clicking on the menu options from the home page.

Who discovered Healios™ ?

Peter M. Anderson, MD, PhD

Peter M. Anderson, MD, PhD. who has served as a Professor, Department of Pediatrics Patient Care, Division of Pediatrics, Curtis Distinguished Professor, The University of Texas MD Anderson Cancer Center, Houston, TX originally developed the science and patents that formed the foundation for Healios™. Dr. Anderson, is now a Staff Physician at the Cleveland Clinic.

Dr. Anderson discovered the benefits of supplementing the amino acid glutamine (a key ingredient in Healios™) as part of his cancer patients’ treatment to reduce the toxic side effects of therapy in the 1990’s. He was seeking to address the well-known side effects involving the mouth caused by cancer treatments. Biological regimens, chemotherapy, and radiation can have moderate or severe effects on the digestive tract where lost epithelial cells are not replaced at an adequate rate. The cumulative damage to the epithelial lining quickly leads to problems in mouth comfort and difficulty in swallowing, leading to decreased nutrient absorption and a pattern of diminished nutrition and increased damage.

How did Dr. Anderson discover the benefits of the Healios™ glutamine suspension for the treatment of cancer-related mucositis?

Dr. Anderson was able to find a way to greatly increase the absorption of glutamine by a factor of over 1,000 times by putting it in a suspension that would “feed the digestive lining” specifically in the mouth, throat, and esophagus. By combining glutamine with a blend of synergistic ingredients, he was able to achieve the desired effect, while still keeping the taste good and the suspension easy to use for patients. The concept was tested successfully in people with cancer in one pilot study and 3 larger randomized placebo, double-blind trials. The HEALIOS™ formula is an improved result of Dr. Anderson’s original research.

How did Healios™ Oncology Nutrition come together?

After years of patient testing and refining the formula, Dr. Anderson partnered with a team of top oncologists and a world-class nutraceutical company to achieve his dream of making Healios™ available to patients world-wide.  Dr. Anderson is on a mission to make Healios™ a part of the standard dietary regimen for those who need it, so that he can improve the lives of as many patients as possible. 

Click Here For More Information About Dr. Anderson + -

Peter M. Anderson, MD, PhD

Present Title & Affiliation

Current Occupation

Staff Physician, The Cleveland Clinic.

Primary Appointment

  • Professor
  • Carolinas HealthCare System

 

 

Education & Training

Degree-Granting Education

1981 Mt. Sinai School of Medicine, New York, NY, MD, Medicine
1980 City University of New York, New York, NY, PHD, Biomedical Sciences
1975 University of Minnesota, Minneapolis, MN, BA, Summa Cum Laude, Psychology

Postgraduate Training

1/1985-1/1988 Hematology/Oncology/Bone Marrow Transplant Fellowship, University of Minnesota, Minneapolis, MN
1/1981-1/1985 Combined Internal Medicine and Pediatrics Residency, Duke University Medical Center, Durham, NC

Board Certifications

1/1987 Pediatric Hematology/Oncology
1/1987 Internal Medicine
1/1986 Pediatrics

Honors and Awards

Alpha Omega Alpha, 1980
Career Development Award, American Cancer Society, 1989
Excellent in Teaching Award- Mayo Medical School, 2003
Annie Weber Memorial Lecture, MACC Fund, 2008
Curtis Distinguished Professor, 2009-2013
MD Anderson, Outstanding Patient Educator, 2010
MD Anderson Pediatric Physician Excellence in Teaching Award- from fellows 2012
MD Anderson Pediatric Physician Excellence in Teaching Award- from Residents 2012
Sarcoma Alliance Outstanding Care Award-2012
Kufos Lecture, Akron Children’s Hospital  2012
Visiting Lecturer, Midland Memorial Hospital, Midland TX 3-6-13 “ Sarcomas in young People”
Visiting Professor and Royal Dames of Ocala Lecture, University of Florida Shands Cancer Center and Univ FL Veterinary Teaching Hospital, Gainesville FL 4/10/13. “New Information to improve Pediatric Cancer Care and Sarcoma Care

Professional Memberships

American Society of Clinical Oncology 
member, 1987-present
American Society of Hematology 
member, 1987-present
American Society of Pediatric Hematology/Oncology 
member, 1987-present
Connective Tissue Oncology Society 
member, 1995-present
Sarcoma Alliance for Research through Collaboration (SARC)
member, 2001-present
Societe Internationale D'Oncologie Pediatrique/ International Society of Paediatric Oncology 
member, 1995-present